Holen Sie sich die Stockscreener-App
19.98
3.43%
-0.71
Finanzdaten der Anika Therapeutics Inc-Aktie (ANIK)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
10.12%
32.61
|
29.61 | 30.61 | 27.82 | 28.22 |
| Cost Of Revenue |
7.07%
11.37
|
10.62 | 11.44 | 12.23 | 13.86 |
| Gross Profit |
11.83%
21.24
|
19.00 | 19.18 | 15.58 | 14.36 |
Selling, General, and Administrative
|
38.39%
10.95
|
17.77 | - | - | - |
| Costs And Expenses |
25.30%
18.29
|
24.48 | 18.53 | 18.82 | 18.54 |
| Depreciation and Amortization |
6.97%
1.505
|
1.407 | 1.318 | 1.391 | 1.28 |
| Operating Income/Loss |
153.83%
2.954
|
-5.488 | 0.646 | -3.233 | -4.18 |
| Income/Loss From Continuing Operations Before Tax |
170.11%
3.38
|
-4.821 | 0.764 | -2.236 | -3.966 |
| Income Tax Expense/Benefit, Deferred |
19.44%
0.129
|
0.108 | -0.025 | 0.003 | -0.003 |
| Income Tax Expense/Benefit |
69.79%
0.071
|
0.235 | -1.037 | 0.939 | 0.681 |
| Income/Loss From Continuing Operations After Tax |
165.45%
3.309
|
-5.056 | 1.801 | -3.175 | -4.647 |
| Income/Loss From Discontinued Operations, Net Of Tax |
-
|
- | -1.508 | 0.845 | 0.677 |
| Net Income/Loss |
165.45%
3.309
|
-5.056 | 0.293 | -2.329 | -3.97 |
| Basic Average Shares |
1.49%
13.33
|
13.53 | -0.022 | 14.42 | 14.36 |
| Diluted Average Shares |
1.37%
13.72
|
13.53 | -0.022 | 14.42 | 14.52 |
| Basic Earnings Per Share |
167.57%
0.25
|
-0.37 | 0.02 | -0.16 | -0.28 |
| Diluted Earnings Per Share |
164.86%
0.24
|
-0.37 | 0.02 | -0.16 | -0.28 |
2.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):